摘要:
A process for the preparation of a 4-aminodiphenyl amino derivative which comprises:(a) contacting a hydroxybenzene of the formula ##STR1## wherein R is hydroxyl or amino with an aniline compound of the formula ##STR2## wherein R.sub.1 represents hydrogen or an alkyl radical in the presence of a .gamma.-aluminum oxide containing catalyst; and(b) contacting the product from step (a) with ammonia in the presence of the same .gamma.-aluminum oxide containing catalyst used in step (a).
摘要:
An improvement is described in the process of preparing polymethylene polyphenyl polyamines by condensing aniline and formaldehyde in the presence of an acid catalyst in the initial condensation. The improvement enables the amount of acid which has to be neutralized at the end of the reaction to be substantially reduced or eliminated entirely. This is accomplished without sacrifice of the high level of 4,4'-isomer of di(aminophenyl)methane normally present in the diamine content of the polyamines when a mineral acid catalyst is employed in the condensation. The improvement comprises conducting the initial condensation of aniline and formaldehyde in the presence of a strong acid at a level normally employed to obtain high 4,4'-isomer content in the diamine component of the polyamine product, subjecting the reaction mixture, at the stage at which benzylamine formation is substantially complete, to solvent extraction after adjusting the aniline and water content of the reaction mixture to specified levels, recovering the mixture of benzylamine and excess aniline from the solvent extract and subjecting this mixture (optionally after removal of aniline) to rearrangement to the desired polyamine product in the presence of a catalyst which can be a strong acid (at a level substantially below that used in the initial condensation), or a solid catalyst (diatomaceous earth, clay, zeolite). The aqueous layer remaining after the solvent extraction contains aniline hydrochloride and a minor amount of benzylamine hydrochloride and is recovered and used as part of the reactants employed in a subsequent condensation.
摘要:
An improved process for the preparation of asymmetrical N-phenyl-N'-substituted para-phenylene diamines by the reductive alkylation of para-nitroso-diphenylhydroxylamine with an aldehyde or a ketone in the presence of hydrogen and a hydrogenation catalyst is disclosed. The improvement comprises utilizing as the hydrogenation catalyst (1) one member selected the group consisting of palladium and platinum sulfide, in an amount less than 1%, by weight, based on the weight of para-nitroso-diphenylhydroxylamine, and (2) activated carbon with a specific surface area of at least 700 square meters per gram and an ash content of less than 7.5%, by weight.
摘要:
Compounds of the formula ##SPC1##WhereinR.sub.1 is hydrogen or aliphatic or aromatic carboxylic acyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is fluorine, alkyl of 1 to 4 carbon atoms, trifluoromethyl, cyano, carbamoyl, carboxyl, carbalkoxy, alkoxy, acetyl, 1-hydroxyethyl or ##EQU1## where R.sub.6 and R.sub.7 are each alkyl, cycloalkyl, hydroxy-cycloalkyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino or morpholino, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy (alkyl of 1 to 5 carbon atoms), alkenyl of 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy(cycloalkyl of 5 to 7 carbon atoms), benzyl, morpholinocarbonylmethyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-methyl-piperazino or camphidino,And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as anti-ulcergenics, secretolytics, antitussive, and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.
摘要:
A novel compound for a capping layer, and an organic light emitting device containing the same are disclosed. The compound for a capping layer is represented by Formula 1 below:
摘要:
A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of:
wherein X is a divalent linking moiety; and R1-R10 are each individually H, optionally-substituted alkyl, optionally-substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, halogen, amino, or hydroxy, provided that at least one of R3 or R8 is an optionally-substituted alkyl, a substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, or halogen.
摘要:
The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse/addiction and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
摘要:
A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X is a divalent linking moiety; and R1-R10 are each individually H, optionally-substituted alkyl, optionally-substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, halogen, amino, or hydroxy, provided that at least one of R3 or R8 is an optionally-substituted alkyl, a substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, or halogen.
摘要:
The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
摘要:
A process for the stereoselective preparation of a chiral alcohol or a chiral amine, the process comprising reacting a first prochiral reactant selected from the group consisting of a ketone, an aldehyde, and an imine, with a second reactant comprising a Grignard reagent, in the presence of a chiral trans-diamine of formula (1) as defined herein: Also provided is the use of the chiral trans-diamine of formula (1) in a Grignard reaction and the chiral trans-diamines per se.